CD44 and breast cancer: Although we could detect 0.2% and 0.1% of CD44+/CD24- breast cancer stem cells in NIPBC-1 and NIPBC-2 cell lines respectively (Figure 16); expression of ALDH-positive BCSCs was not found (data not shown).